Jessica M. Gannon

Jessica M. Gannon

Auto-generated profile, based on publicly available information

Jessica M. Gannon

University of Pittsburgh

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Annals of Clinical Psychiatry
Verified
Journal Article
Closed access
JGJessica M. Gannon
Jessica M. Gannon
JBJaspreet Brar
Jaspreet Brar
ARAbhishek Rai
Abhishek Rai
KCK. N. Roy Chengappa
K. N. Roy Chengappa
Background: Extracts of Withania somnifera (WSE), or Ashwagandha, has traditionally been used as an adaptogen in Ayurvedic medicine, and evidence suggests that it may have efficacy in the treatment of psychiatric disorders, including schizophrenia. This secondary analysis reviewed change in depression and anxiety symptoms in a study using WSE as an adjunctive treatment in patients with schizophrenia experiencing an exacerbation of positive symptoms. Methods: We enrolled patients with schizophrenia in a 12-week, randomized, placebo-controlled, double-blind study. Active treatment was with 1,000 mg of standardized WSE. This analysis reviewed outcomes for 66 patients with depression and anxiety symptoms by examining the single-item depression and anxiety-depression cluster subscores extracted from the Positive and Negative Syndrome Scale. Results: Medium effect sizes of 0.683 (95% confidence interval [CI], 0.16 to 1.21) and 0.686 (95% CI, 0.16 to 1.21) favoring WSE over placebo were observed for depression single-item and anxiety-depression cluster scores, respectively. Adverse events were mild and transient. Conclusions: Our findings suggest that WSE may hold promise in the treatment of depression and anxiety symptoms in schizophrenia. While the mechanism of its clinical efficacy requires more exploration, the data suggest that WSE may treat a broad spectrum of symptoms in exacerbated schizophrenia.

20 October 2020 in Psychology and Psychotherapy: Theory, Research and Practice
Verified
Journal Article
Open access
PDF file
HWHelen J. Wood
Helen J. Wood
JGJessica M. Gannon
Jessica M. Gannon
KCK.N. Roy Chengappa
K.N. Roy Chengappa
DSDeepak Kumar Sarpal
Deepak Kumar Sarpal
Digital health has emerged in recent years as a tool to optimize care delivery and promote treatment adherence among individuals with first‐episode psychosis (FEP). Recent mandates for social distancing and sheltering in place due to the COVID‐19 pandemic have catapulted efforts to provide ongoing coordinated specialty care (CSC) on virtual platforms. While prior evidence provides support for the general implementation of virtual individual therapy, there is limited guidance and evidence for the adoption of group teletherapy. Here we describe our efforts to implement group teletherapy for two small cohorts of individuals with FEP receiving care in a coordinated specialty care clinic using methods adopted from Acceptance and Commitment Therapy. We observed high adherence with group visits as well as client satisfaction across groups. Based on our results, we have taken efforts to implement virtual group therapy more permanently in our clinic. Our experience provides guidance and a model for integration of virtual group therapy within CSC. Practitioner points: In‐person group therapy can be adapted as an online treatment modality for individuals with first‐episode psychosis (FEP). Group teletherapy is both accessible and satisfactory to individuals with FEP. Group teletherapy has potential as a more standard and widespread treatment modality within coordinated specialty care for FEP.

14 March 2016 in Academic Psychiatry
Verified
Journal Article
Closed access
PDF file
GWG. Lucy Wilkening
G. Lucy Wilkening
JGJessica M. Gannon
Jessica M. Gannon
CRClint Ross
Clint Ross
JBJessica L. Brennan
Jessica L. Brennan
TFTanya J. Fabian
Tanya J. Fabian
NBNeal J. Benedict
Neal J. Benedict

1 August 2020 in Schizophrenia Research
Verified
Journal Article
Closed access
JGJessica M. Gannon
Jessica M. Gannon
JCJudith Conlogue
Judith Conlogue
RSRobin Sherwood
Robin Sherwood
JNJessica Nichols
Jessica Nichols
JBJuliette R. Ballough
Juliette R. Ballough
KCK.N. Roy Chengappa
K.N. Roy Chengappa

1 October 2021 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
JGJessica M. Gannon
Jessica M. Gannon
ALAna Lupu
Ana Lupu
JBJaspreet Brar
Jaspreet Brar
MBMyranda Brandt
Myranda Brandt
SZSusanna Zawacki
Susanna Zawacki
KCK. N.ROy Chengappa
K. N.ROy Chengappa

1 August 2020 in Schizophrenia Research
Verified
Journal Article
Open access
JNJessica Nichols
Jessica Nichols
JGJessica M. Gannon
Jessica M. Gannon
JCJudith Conlogue
Judith Conlogue
DSDeepak Kumar Sarpal
Deepak Kumar Sarpal
JMJamie L. Montgomery
Jamie L. Montgomery
KCK.N. Roy Chengappa
K.N. Roy Chengappa